<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33467517</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">814</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22020814</ELocationID><Abstract><AbstractText>Vascular endothelial growth factor (VEGF) was initially characterized as a potent angiogenic factor based on its activity on the vascular system. However, it is now well established that VEGF also plays a crucial role as a neuroprotective factor in the nervous system. A deficit of VEGF has been related to motoneuronal degeneration, such as that occurring in amyotrophic lateral sclerosis (ALS). Strikingly, motoneurons of the oculomotor system show lesser vulnerability to neurodegeneration in ALS compared to other motoneurons. These motoneurons presented higher amounts of VEGF and its receptor Flk-1 than other brainstem pools. That higher VEGF level could be due to an enhanced retrograde input from their target muscles, but it can also be produced by the motoneurons themselves and act in an autocrine way. By contrast, VEGF's paracrine supply from the vicinity cells, such as glial cells, seems to represent a minor source of VEGF for brainstem motoneurons. In addition, ocular motoneurons experiment an increase in VEGF and Flk-1 level in response to axotomy, not observed in facial or hypoglossal motoneurons. Therefore, in this review, we summarize the differences in VEGF availability that could contribute to the higher resistance of extraocular motoneurons to injury and neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva-Hucha</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departamento de Fisiolog&#xed;a, Facultad de Biolog&#xed;a, Universidad de Sevilla, 41012 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor</LastName><ForeName>Angel M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-6213-7454</Identifier><AffiliationInfo><Affiliation>Departamento de Fisiolog&#xed;a, Facultad de Biolog&#xed;a, Universidad de Sevilla, 41012 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morcuende</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1471-7005</Identifier><AffiliationInfo><Affiliation>Departamento de Fisiolog&#xed;a, Facultad de Biolog&#xed;a, Universidad de Sevilla, 41012 Sevilla, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BFU2015-64515-P</GrantID><Agency>Ministerio de Econom&#xed;a y Competitividad</Agency><Country/></Grant><Grant><GrantID>PGC2018-094654-B-100</GrantID><Agency>Ministerio de Econom&#xed;a y Competitividad</Agency><Country/></Grant><Grant><GrantID>BIO-297</GrantID><Agency>Consejer&#xed;a de Econom&#xed;a, Innovaci&#xf3;n, Ciencia y Empleo, Junta de Andaluc&#xed;a</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D040301">Vascular Endothelial Growth Factor Receptor-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065838" MajorTopicYN="N">Oculomotor Nuclear Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040301" MajorTopicYN="N">Vascular Endothelial Growth Factor Receptor-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VEGF</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">axotomy</Keyword><Keyword MajorTopicYN="N">motoneurons</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">oculomotor system</Keyword><Keyword MajorTopicYN="N">trophic factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33467517</ArticleId><ArticleId IdType="pmc">PMC7830098</ArticleId><ArticleId IdType="doi">10.3390/ijms22020814</ArticleId><ArticleId IdType="pii">ijms22020814</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey S.V., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983&#x2013;985. doi: 10.1126/science.6823562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6823562</ArticleId><ArticleId IdType="pubmed">6823562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989;161:851&#x2013;858. doi: 10.1016/0006-291X(89)92678-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(89)92678-8</ArticleId><ArticleId IdType="pubmed">2735925</ArticleId></ArticleIdList></Reference><Reference><Citation>Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D.T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309&#x2013;1312. doi: 10.1126/science.2479987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2479987</ArticleId><ArticleId IdType="pubmed">2479987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara N., Gerber H.-P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003;9:669&#x2013;676. doi: 10.1038/nm0603-669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0603-669</ArticleId><ArticleId IdType="pubmed">12778165</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001;28:131&#x2013;138. doi: 10.1038/88842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88842</ArticleId><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimmond S., Lagercrantz J., Drinkwater C., Silins G., Townson S., Pollock P., Gotley D., Carson E., Rakar S., Nordenskj&#xf6;ld M., et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res. 1996;6:124&#x2013;131. doi: 10.1101/gr.6.2.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.6.2.124</ArticleId><ArticleId IdType="pubmed">8919691</ArticleId></ArticleIdList></Reference><Reference><Citation>Olofsson B., Pajusola K., Kaipainen A., Von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R.F., Alitalo K., Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA. 1996;93:2576&#x2013;2581. doi: 10.1073/pnas.93.6.2576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.6.2576</ArticleId><ArticleId IdType="pmc">PMC39839</ArticleId><ArticleId IdType="pubmed">8637916</ArticleId></ArticleIdList></Reference><Reference><Citation>Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996;15:290&#x2013;298. doi: 10.1002/j.1460-2075.1996.tb00359.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb00359.x</ArticleId><ArticleId IdType="pmc">PMC449944</ArticleId><ArticleId IdType="pubmed">8617204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Gray A., Yuan J., Luoh S.M., Avraham H., Wood W.I. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA. 1996;93:1988&#x2013;1992. doi: 10.1073/pnas.93.5.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.5.1988</ArticleId><ArticleId IdType="pmc">PMC39896</ArticleId><ArticleId IdType="pubmed">8700872</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlandini M., Marconcini L., Ferruzzi R., Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc. Natl. Acad. Sci. USA. 1996;93:11675&#x2013;11680. doi: 10.1073/pnas.93.21.11675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.21.11675</ArticleId><ArticleId IdType="pmc">PMC38117</ArticleId><ArticleId IdType="pubmed">8876195</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada Y., Nezu J.I., Shimane M., Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997;42:483&#x2013;488. doi: 10.1006/geno.1997.4774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1997.4774</ArticleId><ArticleId IdType="pubmed">9205122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 1998;273:31273&#x2013;31282. doi: 10.1074/jbc.273.47.31273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.47.31273</ArticleId><ArticleId IdType="pubmed">9813035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki Y., Takani K., Atoda H., Morita T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF Receptor 2) J. Biol. Chem. 2003;278:51985&#x2013;51988. doi: 10.1074/jbc.C300454200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C300454200</ArticleId><ArticleId IdType="pubmed">14600159</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA. 1991;88:9267&#x2013;9271. doi: 10.1073/pnas.88.20.9267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.20.9267</ArticleId><ArticleId IdType="pmc">PMC52695</ArticleId><ArticleId IdType="pubmed">1924389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathasivam S. VEGF and ALS. Neurosci. Res. 2008;62:71&#x2013;77. doi: 10.1016/j.neures.2008.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2008.06.008</ArticleId><ArticleId IdType="pubmed">18656504</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 2002;99:11946&#x2013;11950. doi: 10.1073/pnas.182296499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.182296499</ArticleId><ArticleId IdType="pmc">PMC129374</ArticleId><ArticleId IdType="pubmed">12181492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., Van Marion I., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003;34:383&#x2013;394. doi: 10.1038/ng1211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1211</ArticleId><ArticleId IdType="pubmed">12847526</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Tjwa M., Van Hove I., Enholm B., Neven E., Paavonen K., Juan T.D., Sievers R.E., Chorianopoulos E., Wada H., et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arter. Thromb. Vasc. Biol. 2008;28:1614&#x2013;1620. doi: 10.1161/ATVBAHA.107.158725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.158725</ArticleId><ArticleId IdType="pmc">PMC2753879</ArticleId><ArticleId IdType="pubmed">18511699</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., Lambrechts D., Van Damme P., Dhondt J., Bender F., Frank N., Bogaert E., Claes B., Heylen L., Verheyen A., et al. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J. Neurosci. 2008;28:10451&#x2013;10459. doi: 10.1523/JNEUROSCI.1092-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1092-08.2008</ArticleId><ArticleId IdType="pmc">PMC6671326</ArticleId><ArticleId IdType="pubmed">18923022</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmeliet P., Ruiz de Almodovar C. VEGF ligands and receptors: Implications in neurodevelopment and neurodegeneration. Cell. Mol. Life Sci. 2013;70:1763&#x2013;1778. doi: 10.1007/s00018-013-1283-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1283-7</ArticleId><ArticleId IdType="pubmed">23475071</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2:1097&#x2013;1105. doi: 10.1177/1947601911423031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1947601911423031</ArticleId><ArticleId IdType="pmc">PMC3411125</ArticleId><ArticleId IdType="pubmed">22866201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., Madri J.A., Ment L.R. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 2002;277:11410&#x2013;11415. doi: 10.1074/jbc.M111085200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111085200</ArticleId><ArticleId IdType="pubmed">11777931</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Storkebaum E., Vleminckx V., Moons L., Vanopdenbosch L., Scheveneels W., Carmeliet P., Robberecht W. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiol. Dis. 2004;17:21&#x2013;28. doi: 10.1016/j.nbd.2004.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2004.06.004</ArticleId><ArticleId IdType="pubmed">15350962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ijichi A., Sakuma S., Tofilon P.J. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia. 1995;14:87&#x2013;93. doi: 10.1002/glia.440140203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440140203</ArticleId><ArticleId IdType="pubmed">7558244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartholdi D., Rubin B.P., Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 1997;9:2549&#x2013;2560. doi: 10.1111/j.1460-9568.1997.tb01684.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1997.tb01684.x</ArticleId><ArticleId IdType="pubmed">9517460</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman W.F., Krum J.M., Mani N., Rosenstein J.M. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 1999;90:1529&#x2013;1541. doi: 10.1016/S0306-4522(98)00540-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(98)00540-5</ArticleId><ArticleId IdType="pubmed">10338318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res. 1999;846:219&#x2013;228. doi: 10.1016/S0006-8993(99)02056-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)02056-9</ArticleId><ArticleId IdType="pubmed">10556639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 1999;19:5731&#x2013;5740. doi: 10.1523/JNEUROSCI.19-14-05731.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-14-05731.1999</ArticleId><ArticleId IdType="pmc">PMC6783109</ArticleId><ArticleId IdType="pubmed">10407014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 2000;12:4243&#x2013;4254. doi: 10.1046/j.0953-816X.2000.01326.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0953-816X.2000.01326.x</ArticleId><ArticleId IdType="pubmed">11122336</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA. 2000;97:10242&#x2013;10247. doi: 10.1073/pnas.97.18.10242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.18.10242</ArticleId><ArticleId IdType="pmc">PMC27841</ArticleId><ArticleId IdType="pubmed">10963684</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson B., Peters M., K&#xf6;nig H.G., Poppe M., Levkau B., Rothermundt M., Arolt V., K&#xf6;gel D., Prehn J.H.M. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 2002;22:1170&#x2013;1175. doi: 10.1097/01.wcb.0000037988.07114.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wcb.0000037988.07114.98</ArticleId><ArticleId IdType="pubmed">12368654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wick A., Wick W., Waltenberger J., Weller M., Dichgans J., Schulz J.B. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 2002;22:6401&#x2013;6407. doi: 10.1523/JNEUROSCI.22-15-06401.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-15-06401.2002</ArticleId><ArticleId IdType="pmc">PMC6758162</ArticleId><ArticleId IdType="pubmed">12151519</ArticleId></ArticleIdList></Reference><Reference><Citation>Licht T., Goshen I., Avital A., Kreisel T., Zubedat S., Eavri R., Segal M., Yirmiya R., Keshet E. Reversible modulations of neuronal plasticity by VEGF. Proc. Natl. Acad. Sci. USA. 2011;108:5081&#x2013;5086. doi: 10.1073/pnas.1007640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007640108</ArticleId><ArticleId IdType="pmc">PMC3064368</ArticleId><ArticleId IdType="pubmed">21385942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz de Almodovar C., Lambrechts D., Mazzone M., Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 2009;89:607&#x2013;648. doi: 10.1152/physrev.00031.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00031.2008</ArticleId><ArticleId IdType="pubmed">19342615</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Xu W., Luo C., Gozal D., Liu R. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Mol. Brain Res. 2003;111:155&#x2013;164. doi: 10.1016/S0169-328X(03)00025-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(03)00025-1</ArticleId><ArticleId IdType="pubmed">12654515</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo L.B., Zepeda A., Tapia R. Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J. Neuropathol. Exp. Neurol. 2007;66:913&#x2013;922. doi: 10.1097/nen.0b013e3181567c16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e3181567c16</ArticleId><ArticleId IdType="pubmed">17917585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa L., Mir M., Asensio V.J., Olmos G., Llad&#xf3; J. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem. 2008;105:1080&#x2013;1090. doi: 10.1111/j.1471-4159.2007.05206.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05206.x</ArticleId><ArticleId IdType="pubmed">18182045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo L.B., Tapia R. VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. J. Neurochem. 2010;115:1090&#x2013;1101. doi: 10.1111/j.1471-4159.2010.06766.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06766.x</ArticleId><ArticleId IdType="pubmed">20456006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz de Almodovar C., Fabre P.J., Knevels E., Coulon C., Segura I., Haddick P.C.G., Aerts L., Delattin N., Strasser G., Oh W.-J., et al. VEGF mediates commissural axon chemoattraction through its receptor Flk1. Neuron. 2011;70:966&#x2013;978. doi: 10.1016/j.neuron.2011.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.04.014</ArticleId><ArticleId IdType="pmc">PMC3638787</ArticleId><ArticleId IdType="pubmed">21658588</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Wharton S.B., Fernando M., Gelsthorpe C.H., Baxter L., Ince P.G., Lewis C.E., Shaw P.J. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2006;65:26&#x2013;36. doi: 10.1097/01.jnen.0000196134.51217.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000196134.51217.74</ArticleId><ArticleId IdType="pubmed">16410746</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992;267:10931&#x2013;10934. doi: 10.1016/S0021-9258(19)49853-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)49853-0</ArticleId><ArticleId IdType="pubmed">1375931</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-&#x3b2; in fibroblastic and epithelial cells. J. Biol. Chem. 1994;269:6271&#x2013;6274. doi: 10.1016/S0021-9258(17)37365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)37365-9</ArticleId><ArticleId IdType="pubmed">8119973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T., Nahari D., Cerem L.W., Neufeld G., Levin B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996;271:736&#x2013;741. doi: 10.1074/jbc.271.2.736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.2.736</ArticleId><ArticleId IdType="pubmed">8557680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., Kuwano M. Induction of vascular endothelial growth factor by tumor necrosis factor &#x3b1; in human glioma cells: Possible roles of SP-1. J. Biol. Chem. 1996;271:28220&#x2013;28228. doi: 10.1074/jbc.271.45.28220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.45.28220</ArticleId><ArticleId IdType="pubmed">8910439</ArticleId></ArticleIdList></Reference><Reference><Citation>Deroanne C.F., Hajitou A., Calberg-Bacq C.M., Nusgens B.V., Lapi&#xe8;re C.M. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res. 1997;57:5590&#x2013;5597.</Citation><ArticleIdList><ArticleId IdType="pubmed">9407972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroll J., Waltenberger J. A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem. Biophys. Res. Commun. 1999;265:636&#x2013;639. doi: 10.1006/bbrc.1999.1729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1729</ArticleId><ArticleId IdType="pubmed">10600473</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B.Q., Lee D.Y., Zioncheck T.F. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J. Biol. Chem. 1999;274:33057&#x2013;33063. doi: 10.1074/jbc.274.46.33057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.46.33057</ArticleId><ArticleId IdType="pubmed">10551875</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard D.E., Berra E., Pouyss&#xe9;gur J. Angiogenesis: How a tumor adapts to hypoxia. Biochem. Biophys. Res. Commun. 1999;266:718&#x2013;722. doi: 10.1006/bbrc.1999.1889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1889</ArticleId><ArticleId IdType="pubmed">10603309</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein I., Neeman M., Shweiki D., Itin A., Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 1995;15:5363&#x2013;5368. doi: 10.1128/MCB.15.10.5363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.15.10.5363</ArticleId><ArticleId IdType="pmc">PMC230785</ArticleId><ArticleId IdType="pubmed">7565686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda E., Achen M.G., Breier G., Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 1995;270:19761&#x2013;19766. doi: 10.1074/jbc.270.34.19761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.34.19761</ArticleId><ArticleId IdType="pubmed">7544346</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996;16:4604&#x2013;4613. doi: 10.1128/MCB.16.9.4604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.16.9.4604</ArticleId><ArticleId IdType="pmc">PMC231459</ArticleId><ArticleId IdType="pubmed">8756616</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenza G.L. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 1998;8:588&#x2013;594. doi: 10.1016/S0959-437X(98)80016-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-437X(98)80016-6</ArticleId><ArticleId IdType="pubmed">9794818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaelin W.G. HIF2 inhibitor joins the kidney cancer armamentarium. J. Clin. Oncol. 2018;36:908&#x2013;910. doi: 10.1200/JCO.2017.77.5254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2017.77.5254</ArticleId><ArticleId IdType="pubmed">29384723</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 1995;270:13333&#x2013;13340. doi: 10.1074/jbc.270.22.13333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.22.13333</ArticleId><ArticleId IdType="pubmed">7768934</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: Identification of a 5&#x2019; enhancer. Circ. Res. 1995;77:638&#x2013;643. doi: 10.1161/01.RES.77.3.638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.77.3.638</ArticleId><ArticleId IdType="pubmed">7641334</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenza G.L., Prabhakar N.R. The role of hypoxia-inducible factors in carotid body (patho) physiology. J. Physiol. 2018;596:2977&#x2013;2983. doi: 10.1113/JP275696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP275696</ArticleId><ArticleId IdType="pmc">PMC6068252</ArticleId><ArticleId IdType="pubmed">29359806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratcliffe P.J., Ebert B.L., Ferguson D.J.P., Firth J.D., Gleadle J.M., Maxwell P.H., Pugh C.W. State of the art lecture: Regulation of the erythropoietin gene. Nephrol. Dial. Transplant. 1995;10:18&#x2013;27. doi: 10.1093/ndt/10.supp2.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/10.supp2.18</ArticleId><ArticleId IdType="pubmed">7644101</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenza G.L. Expression of hypoxia-inducible factor 1: Mechanisms and consequences. Biochem. Pharmacol. 2000;59:47&#x2013;53. doi: 10.1016/S0006-2952(99)00292-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-2952(99)00292-0</ArticleId><ArticleId IdType="pubmed">10605934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenger R.H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 2000;203:1253&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">10729275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., Ginty D.D. Neuropilin is a semaphorin III receptor. Cell. 1997;90:753&#x2013;762. doi: 10.1016/S0092-8674(00)80535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80535-8</ArticleId><ArticleId IdType="pubmed">9288754</ArticleId></ArticleIdList></Reference><Reference><Citation>Giger R.J., Urquhart E.R., Gillespie S.K.H., Levengood D.V., Ginty D.D., Kolodkin A.L. Neuropilin-2 is a receptor for semaphorin IV: Insight into the structural basis of receptor function and specificity. Neuron. 1998;21:1079&#x2013;1092. doi: 10.1016/S0896-6273(00)80625-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80625-X</ArticleId><ArticleId IdType="pubmed">9856463</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker G.B., Limberg B.J., Rosenbaum J.S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121. J. Biol. Chem. 2001;276:25520&#x2013;25531. doi: 10.1074/jbc.M102315200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M102315200</ArticleId><ArticleId IdType="pubmed">11333271</ArticleId></ArticleIdList></Reference><Reference><Citation>Geretti E., Shimizu A., Klagsbrun M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis. 2008;11:31&#x2013;39. doi: 10.1007/s10456-008-9097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-008-9097-1</ArticleId><ArticleId IdType="pubmed">18283547</ArticleId></ArticleIdList></Reference><Reference><Citation>Llad&#xf3; J., Tolosa L., Olmos G. Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons. Front. Cell. Neurosci. 2013;7:181. doi: 10.3389/fncel.2013.00181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00181</ArticleId><ArticleId IdType="pmc">PMC3803143</ArticleId><ArticleId IdType="pubmed">24155688</ArticleId></ArticleIdList></Reference><Reference><Citation>Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 2003;9:936&#x2013;943. doi: 10.1038/nm884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm884</ArticleId><ArticleId IdType="pubmed">12796773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachary I. Neuroprotective role of vascular endothelial growth factor: Signalling mechanisms, biological function, and therapeutic potential. NeuroSignals. 2005;14:207&#x2013;221. doi: 10.1159/000088637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000088637</ArticleId><ArticleId IdType="pubmed">16301836</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005;8:85&#x2013;92. doi: 10.1038/nn1360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1360</ArticleId><ArticleId IdType="pubmed">15568021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Van Damme P., Van Den Bosch L., Robberecht W. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve. 2006;34:391&#x2013;405. doi: 10.1002/mus.20609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20609</ArticleId><ArticleId IdType="pubmed">16856151</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster F.M., Traer C.J., Abraham S.M., Fry M.J. The phosphoinositide (PI) 3-kinase family. J. Cell Sci. 2003;116:3037&#x2013;3040. doi: 10.1242/jcs.00609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00609</ArticleId><ArticleId IdType="pubmed">12829733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa L., Mir M., Olmos G., Llad&#xf3; J. Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience. 2009;158:1348&#x2013;1355. doi: 10.1016/j.neuroscience.2008.10.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.10.060</ArticleId><ArticleId IdType="pubmed">19041930</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiote M., Nagano I., Ilieva H., Murakami T., Narai H., Ohta Y., Nagata T., Shoji M., Abe K. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia. Neuroscience. 2005;132:175&#x2013;182. doi: 10.1016/j.neuroscience.2004.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.12.031</ArticleId><ArticleId IdType="pubmed">15780476</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Vande Velde C., Cleveland D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Sims K.B., Xin W.W., Kiely R., O&#x2019;Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2003;4:62&#x2013;73. doi: 10.1080/14660820310011700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011700</ArticleId><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zheng L., Viera L., Suswam E., Li Y., Li X., Est&#xe9;vez A.G., King P.H. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J. Neurosci. 2007;27:7929&#x2013;7938. doi: 10.1523/JNEUROSCI.1877-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1877-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672720</ArticleId><ArticleId IdType="pubmed">17652584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Gonzalez de Aguilar J.L., Echaniz-Laguna A., Eschbach J., Rene F., Oudart H., Halter B., Huze C., Schaeffer L., Bouillaud F., et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390. doi: 10.1371/journal.pone.0005390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebasti&#xe3;o A.M., Ribeiro J.A. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS ONE. 2013;8:e73846. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E., Carmeliet P. VEGF: A critical player in neurodegeneration. J. Clin. Investig. 2004;113:14&#x2013;18. doi: 10.1172/JCI20682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI20682</ArticleId><ArticleId IdType="pmc">PMC300888</ArticleId><ArticleId IdType="pubmed">14702101</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E., Lambrechts D., Carmeliet P. VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays. 2004;26:943&#x2013;954. doi: 10.1002/bies.20092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20092</ArticleId><ArticleId IdType="pubmed">15351965</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413&#x2013;417. doi: 10.1038/nature02544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02544</ArticleId><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang D.H., Lee H.J., Park I.H., Seok J.I., Kim B.G., Joo I.S., Kim S.U. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009;16:1234&#x2013;1244. doi: 10.1038/gt.2009.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2009.80</ArticleId><ArticleId IdType="pubmed">19626053</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould T.W., Oppenheim R.W. Motor neuron trophic factors: Therapeutic use in ALS? Brain Res. Rev. 2011;67:1&#x2013;39. doi: 10.1016/j.brainresrev.2010.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2010.10.003</ArticleId><ArticleId IdType="pmc">PMC3109102</ArticleId><ArticleId IdType="pubmed">20971133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstein J.M., Mani N., Khaibullina A., Krum J.M. Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J. Neurosci. 2003;23:11036&#x2013;11044. doi: 10.1523/JNEUROSCI.23-35-11036.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-35-11036.2003</ArticleId><ArticleId IdType="pmc">PMC6741059</ArticleId><ArticleId IdType="pubmed">14657160</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., Cleveland D.W. VEGF: Multitasking in ALS. Nat. Neurosci. 2005;8:5&#x2013;7. doi: 10.1038/nn0105-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn0105-5</ArticleId><ArticleId IdType="pubmed">15622408</ArticleId></ArticleIdList></Reference><Reference><Citation>Widenfalk J., Lipson A., Jubran M., Hofstetter C., Ebendal T., Cao Y., Olson L. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience. 2003;120:951&#x2013;960. doi: 10.1016/S0306-4522(03)00399-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(03)00399-3</ArticleId><ArticleId IdType="pubmed">12927201</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Tang C., Zhu L., Li J., Liang H., Zhang J., Xu R. The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Int. J. Biol. Sci. 2016;12:1140&#x2013;1149. doi: 10.7150/ijbs.15938.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15938</ArticleId><ArticleId IdType="pmc">PMC4997058</ArticleId><ArticleId IdType="pubmed">27570488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 1998;273:13313&#x2013;13316. doi: 10.1074/jbc.273.21.13313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.21.13313</ArticleId><ArticleId IdType="pubmed">9582377</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona J.C., Tapia R. Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacology. 2007;52:1219&#x2013;1228. doi: 10.1016/j.neuropharm.2006.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2006.12.008</ArticleId><ArticleId IdType="pubmed">17320918</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia R., Medina-Ceja L., Pe&#xf1;a F. On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo. Neurochem. Int. 1999;34:23&#x2013;31. doi: 10.1016/S0197-0186(98)00061-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(98)00061-8</ArticleId><ArticleId IdType="pubmed">10100193</ArticleId></ArticleIdList></Reference><Reference><Citation>Meldrum B.S. Glutamate and glutamine in the brain glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J. Nutr. 2018;130:1007S&#x2013;1015S. doi: 10.1093/jn/130.4.1007S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/130.4.1007S</ArticleId><ArticleId IdType="pubmed">10736372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994;330:613&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">7905600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettler B., Mulle C. AMPA and kainate receptors. Neuropharmacology. 1995;34:123&#x2013;139. doi: 10.1016/0028-3908(94)00141-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0028-3908(94)00141-E</ArticleId><ArticleId IdType="pubmed">7542368</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:438&#x2013;458. doi: 10.1002/mus.10186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10186</ArticleId><ArticleId IdType="pubmed">12362409</ArticleId></ArticleIdList></Reference><Reference><Citation>Siesjo B.K. Calcium-mediated processes in neuronal degeneration. Ann. N. Y. Acad. Sci. 1994;747:140&#x2013;161. doi: 10.1111/j.1749-6632.1994.tb44406.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1994.tb44406.x</ArticleId><ArticleId IdType="pubmed">7847668</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Vandenberghe W., Klaassen H., Van Houtte E., Robberecht W. Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons. J. Neurol. Sci. 2000;180:29&#x2013;34. doi: 10.1016/S0022-510X(00)00414-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00414-7</ArticleId><ArticleId IdType="pubmed">11090861</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J. Neurophysiol. 2002;88:1279&#x2013;1287. doi: 10.1152/jn.2002.88.3.1279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2002.88.3.1279</ArticleId><ArticleId IdType="pubmed">12205149</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Braeken D., Callewaert G., Robberecht W., Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2005;64:605&#x2013;612. doi: 10.1097/01.jnen.0000171647.09589.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000171647.09589.07</ArticleId><ArticleId IdType="pubmed">16042312</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo S.G., Sensi S.L., Yin H.Z., Weiss J.H. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J. Neurosci. 2000;20:240&#x2013;250. doi: 10.1523/JNEUROSCI.20-01-00240.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-01-00240.2000</ArticleId><ArticleId IdType="pmc">PMC6774118</ArticleId><ArticleId IdType="pubmed">10627601</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16:675&#x2013;686. doi: 10.1016/S0896-6273(00)80086-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80086-0</ArticleId><ArticleId IdType="pubmed">8785064</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., Mitsuda N., Tohyama M. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: Signal transduction cascades. FASEB J. 2001;15:1218&#x2013;1220. doi: 10.1096/fj.00-0495fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.00-0495fje</ArticleId><ArticleId IdType="pubmed">11344093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Van Damme P., Poesen K., Dhondt J., Hersmus N., Kiraly D., Scheveneels W., Robberecht W., Van Den Bosch L. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol. Aging. 2010;31:2185&#x2013;2191. doi: 10.1016/j.neurobiolaging.2008.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.12.007</ArticleId><ArticleId IdType="pubmed">19185395</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimchinsky E.A., Young W.G., Yeung G., Shah R.A., Gordon J.W., Bloom F.E., Morrison J.H., Hof P.R. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 2000;416:112&#x2013;125. doi: 10.1002/(SICI)1096-9861(20000103)416:1&lt;112::AID-CNE9&gt;3.0.CO;2-K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(20000103)416:1&lt;112::AID-CNE9&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">10578106</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenggeli C., Kato A.C. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci. Lett. 2002;335:39&#x2013;43. doi: 10.1016/S0304-3940(02)01140-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(02)01140-0</ArticleId><ArticleId IdType="pubmed">12457737</ArticleId></ArticleIdList></Reference><Reference><Citation>DePaul R., Abbs J.H., Caligiuri M., Gracco V.L., Brooks B.R. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology. 1988;38:281&#x2013;283. doi: 10.1212/WNL.38.2.281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.2.281</ArticleId><ArticleId IdType="pubmed">3340294</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Ning K., Heath P.R., Wood E., Kirby J., Fusi N., Lawrence N., Wharton S.B., Ince P.G., Shaw P.J. Unravelling the enigma of selective vulnerability in neurodegeneration: Motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125:95&#x2013;109. doi: 10.1007/s00401-012-1058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L., Allodi I., Nichterwitz S., Nizzardo M., Simone C., Corti S., Hedlund E. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience. 2015;291:216&#x2013;229. doi: 10.1016/j.neuroscience.2015.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.013</ArticleId><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner A., Medina L., Figueredo-Cardenas G., Anfinson S. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: Evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp. Neurol. 1995;131:239&#x2013;250. doi: 10.1016/0014-4886(95)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4886(95)90046-2</ArticleId><ArticleId IdType="pubmed">7895823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjust A.E., Brannstrom T., Pedrosa Domellof F. Unaffected motor endplate occupancy in eye muscles of ALS G93A mouse model. Front. Biosci. 2012:1547&#x2013;1555.</Citation><ArticleIdList><ArticleId IdType="pubmed">22652891</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.X., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Pedrosa-Domell&#xf6;f F. Different impact of ALS on laminin isoforms in human extraocular muscles versus limb muscles. Investig. Ophthalmol. Vis. Sci. 2011;52:4842&#x2013;4852. doi: 10.1167/iovs.10-7132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-7132</ArticleId><ArticleId IdType="pubmed">21372009</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M.E., Ho B., Mohamed A.H., La Bella V., Smith R.G., Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 1994;36:846&#x2013;858. doi: 10.1002/ana.410360608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360608</ArticleId><ArticleId IdType="pubmed">7998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanselow B.K., Keller B.U. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. Pt 2J. Physiol. 2000;525:433&#x2013;445. doi: 10.1111/j.1469-7793.2000.t01-1-00433.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2000.t01-1-00433.x</ArticleId><ArticleId IdType="pmc">PMC2269959</ArticleId><ArticleId IdType="pubmed">10835045</ArticleId></ArticleIdList></Reference><Reference><Citation>Laslo P., Lipski J., Nicholson L.F., Miles G.B., Funk G.D. Calcium binding proteins in motoneurons at low and high risk for degeneration in ALS. Neuroreport. 2000;11:3305&#x2013;3308. doi: 10.1097/00001756-200010200-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200010200-00009</ArticleId><ArticleId IdType="pubmed">11059892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C.W., Baimbridge K.G. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 1993;19:291&#x2013;299. doi: 10.1111/j.1365-2990.1993.tb00443.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00443.x</ArticleId><ArticleId IdType="pubmed">8232749</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Cruz R.R., Pastor A.M., Mart&#xed;nez-Guijarro F.J., L&#xf3;pez-Garc&#xed;a C., Delgado-Garc&#xed;a J.M. Localization of parvalbumin, calretinin, and calbindin D-28k in identified extraocular motoneurons and internuclear neurons of the cat. J. Comp. Neurol. 1998;390:377&#x2013;391. doi: 10.1002/(SICI)1096-9861(19980119)390:3&lt;377::AID-CNE6&gt;3.0.CO;2-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19980119)390:3&lt;377::AID-CNE6&gt;3.0.CO;2-Z</ArticleId><ArticleId IdType="pubmed">9455899</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Ho B.K., Sikl&#xf3;s L., Alexianu M.E., Mosier D.R., Habib Mohamed A., Otsuka Y., Kozovska M.E., McAlhany R.E., Glenn Smith R., et al. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 2001;79:499&#x2013;509. doi: 10.1046/j.1471-4159.2001.00582.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00582.x</ArticleId><ArticleId IdType="pubmed">11701753</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Schwaller B., Vleminckx V., Meijers B., Stork S., Ruehlicke T., Van Houtte E., Klaassen H., Celio M.R., Missiaen L., et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp. Neurol. 2002;174:150&#x2013;161. doi: 10.1006/exnr.2001.7858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7858</ArticleId><ArticleId IdType="pubmed">11922657</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuoka T., Tokunaga A., Kondo E., Miki K., Tachibana T., Noguchi K. Differential regulation of alpha- and beta-CGRP mRNAs within oculomotor, trochlear, abducens, and trigeminal motoneurons in response to axotomy. Mol. Brain Res. 1999;63:304&#x2013;315. doi: 10.1016/S0169-328X(98)00297-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(98)00297-6</ArticleId><ArticleId IdType="pubmed">9878800</ArticleId></ArticleIdList></Reference><Reference><Citation>Morcuende S., Matarredona E.R., Ben&#xed;tez-Temi&#xf1;o B., Mu&#xf1;oz-Hern&#xe1;ndez R., Pastor A.M., de la Cruz R.R. Differential regulation of the expression of neurotrophin receptors in rat extraocular motoneurons after lesion. J. Comp. Neurol. 2011;519:2335&#x2013;2352. doi: 10.1002/cne.22630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22630</ArticleId><ArticleId IdType="pubmed">21456016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Forero D., de la Cruz R.R., Delgado-Garc&#xed;a J.M., &#xc1;lvarez F.J., Pastor A.M. Correlation between CGRP immunoreactivity and firing activity in cat abducens motoneurons. J. Comp. Neurol. 2002;451:201&#x2013;212. doi: 10.1002/cne.10267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.10267</ArticleId><ArticleId IdType="pubmed">12210133</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I., Comley L., Nichterwitz S., Nizzardo M., Simone C., Aguila Benitez J., Cao M., Corti S., Hedlund E. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS and SMA. Sci. Rep. 2016;6:25960. doi: 10.1038/srep25960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25960</ArticleId><ArticleId IdType="pmc">PMC4867585</ArticleId><ArticleId IdType="pubmed">27180807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund E., Karlsson M., Osborn T., Ludwig W., Isacson O. Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain. 2010;133:2313&#x2013;2330. doi: 10.1093/brain/awq167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq167</ArticleId><ArticleId IdType="pmc">PMC3139939</ArticleId><ArticleId IdType="pubmed">20826431</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808&#x2013;812. doi: 10.1126/science.1083129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083129</ArticleId><ArticleId IdType="pubmed">12730604</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Robertson J., Lariviere R., Mallet J., Julien J.P. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J. Neurochem. 2006;98:926&#x2013;938. doi: 10.1111/j.1471-4159.2006.03932.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03932.x</ArticleId><ArticleId IdType="pubmed">16787413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y.M., Yamamoto M., Tanaka F., Ishigaki S., Katsuno M., Adachi H., Niwa J.I., Doyu M., Yoshida M., Hashizume Y., et al. Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:617&#x2013;627. doi: 10.1097/nen.0b013e318093ece3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318093ece3</ArticleId><ArticleId IdType="pubmed">17620987</ArticleId></ArticleIdList></Reference><Reference><Citation>Collard J.F., C&#xf4;t&#xe9; F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375:61&#x2013;64. doi: 10.1038/375061a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375061a0</ArticleId><ArticleId IdType="pubmed">7536898</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheim R., Haverkamp L., Prevette D., McManaman J., Appel S. Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. Science. 1988;240:919&#x2013;922. doi: 10.1126/science.3363373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3363373</ArticleId><ArticleId IdType="pubmed">3363373</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieshammer U., Lewandoski M., Prevette D., Oppenheim R.W., Martin G.R. Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss. Dev. Biol. 1998;197:234&#x2013;247. doi: 10.1006/dbio.1997.8859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/dbio.1997.8859</ArticleId><ArticleId IdType="pubmed">9630749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould T.W., Yonemura S., Oppenheim R.W., Ohmori S., Enomoto H. The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes. J. Neurosci. 2008;28:2131&#x2013;2146. doi: 10.1523/JNEUROSCI.5185-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5185-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671853</ArticleId><ArticleId IdType="pubmed">18305247</ArticleId></ArticleIdList></Reference><Reference><Citation>DiStefano P.S., Friedman B., Radziejewski C., Alexander C., Boland P., Schick C.M., Lindsay R.M., Wiegand S.J. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 1992;8:983&#x2013;993. doi: 10.1016/0896-6273(92)90213-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90213-W</ArticleId><ArticleId IdType="pubmed">1375039</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliatsos V.E., Crawford T.O., Price D.L. Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons. Brain Res. 1991;549:297&#x2013;304. doi: 10.1016/0006-8993(91)90471-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(91)90471-7</ArticleId><ArticleId IdType="pubmed">1653083</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L.M., Dragunow M. Trk receptor alterations in Alzheimer&#x2019;s disease. Mol. Brain Res. 1996;42:1&#x2013;17. doi: 10.1016/S0169-328X(96)00040-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(96)00040-X</ArticleId><ArticleId IdType="pubmed">8915574</ArticleId></ArticleIdList></Reference><Reference><Citation>Canals J.M., Checa N., Marco S., Michels A., P&#xe9;rez-Navarro E., Alberch J. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum. Mol. Brain Res. 1999;69:242&#x2013;248. doi: 10.1016/S0169-328X(99)00130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(99)00130-8</ArticleId><ArticleId IdType="pubmed">10366745</ArticleId></ArticleIdList></Reference><Reference><Citation>Duprey-D&#xed;az M.V., Soto I., Blagburn J.M., Blanco R.E. Changes in brain-derived neurotrophic factor and trkB receptor in the adult Rana pipiens retina and optic tectum after optic nerve injury. J. Comp. Neurol. 2002;454:456&#x2013;469. doi: 10.1002/cne.10451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.10451</ArticleId><ArticleId IdType="pubmed">12455009</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliatsos V.E., Clatterbuck R.E., Winslow J.W., Cayouette M.H., Prices D.L. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron. 1993;10:359&#x2013;367. doi: 10.1016/0896-6273(93)90326-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(93)90326-M</ArticleId><ArticleId IdType="pubmed">8080464</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlio J.P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience. 1992;51:513&#x2013;532. doi: 10.1016/0306-4522(92)90292-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(92)90292-A</ArticleId><ArticleId IdType="pubmed">1488112</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson C.E., Camu W., Mettling C., Gouin A., Poulsen K., Karihaloo M., Ruilamas J., Evans T., McMahon S.B., Armanini M.P., et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature. 1993;363:266&#x2013;270. doi: 10.1038/363266a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/363266a0</ArticleId><ArticleId IdType="pubmed">8487864</ArticleId></ArticleIdList></Reference><Reference><Citation>Piehl F., Fris&#xe9;n J., Risling M., H&#xf6;kfelt T., Cullheim S. Increased trkB mRNA expression by axotomized motoneurones. Neuroreport. 1994;5:697&#x2013;700. doi: 10.1097/00001756-199402000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199402000-00009</ArticleId><ArticleId IdType="pubmed">8199340</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis-L&#xf3;pez de Carrizosa M.A., Morado-D&#xed;az C.J., Morcuende S., de la Cruz R.R., Pastor A.M. Nerve growth factor regulates the firing patterns and synaptic composition of motoneurons. J. Neurosci. 2010;30:8308&#x2013;8319. doi: 10.1523/JNEUROSCI.0719-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0719-10.2010</ArticleId><ArticleId IdType="pmc">PMC6634574</ArticleId><ArticleId IdType="pubmed">20554882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben&#xed;tez-Temi&#xf1;o B., Morcuende S., Mentis G.Z., de la Cruz R.R., Pastor A.M. Expression of Trk receptors in the oculomotor system of the adult cat. J. Comp. Neurol. 2004;473:538&#x2013;552. doi: 10.1002/cne.20095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20095</ArticleId><ArticleId IdType="pubmed">15116389</ArticleId></ArticleIdList></Reference><Reference><Citation>Morcuende S., Mu&#xf1;oz-Hern&#xe1;ndez R., Ben&#xed;tez-Temi&#xf1;o B., Pastor A.M., de la Cruz R.R. Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats. Neuroscience. 2013;250:31&#x2013;48. doi: 10.1016/j.neuroscience.2013.06.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.06.050</ArticleId><ArticleId IdType="pubmed">23827308</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Hucha S., Hern&#xe1;ndez R.G., Ben&#xed;tez-Temi&#xf1;o B., Pastor A.M., de la Cruz R.R., Morcuende S. Extraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons. PLoS ONE. 2017;12:e0178616. doi: 10.1371/journal.pone.0178616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178616</ArticleId><ArticleId IdType="pmc">PMC5453543</ArticleId><ArticleId IdType="pubmed">28570669</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloskey D.P., Hintz T.M., Scharfman H.E. Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res. Bull. 2008;76:36&#x2013;44. doi: 10.1016/j.brainresbull.2007.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2007.11.018</ArticleId><ArticleId IdType="pmc">PMC2422999</ArticleId><ArticleId IdType="pubmed">18395608</ArticleId></ArticleIdList></Reference><Reference><Citation>Millauer B., Wizigmann-Voos S., Schn&#xfc;rch H., Martinez R., M&#xf8;ller N.P.H., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835&#x2013;846. doi: 10.1016/0092-8674(93)90573-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90573-9</ArticleId><ArticleId IdType="pubmed">7681362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Duan W., Wang W., Wen D., Liu Y., Liu Y., Li Z., Hu H., Lin H., Cui C., et al. scAAV9-VEGF prolongs the survival of transgenic ALS mice by promoting activation of M2 microglia and the PI3K/Akt pathway. Brain Res. 2016;1648:1&#x2013;10. doi: 10.1016/j.brainres.2016.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.06.043</ArticleId><ArticleId IdType="pubmed">27392886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J.E., Manseau E.J., Harvey V.S., et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Investig. 2000;80:99&#x2013;115. doi: 10.1038/labinvest.3780013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3780013</ArticleId><ArticleId IdType="pubmed">10653008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez R.G., Calvo P.M., Blumer R., de la Cruz R.R., Pastor A.M. Functional diversity of motoneurons in the oculomotor system. Proc. Natl. Acad. Sci. USA. 2019;116:3837&#x2013;3846. doi: 10.1073/pnas.1818524116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818524116</ArticleId><ArticleId IdType="pmc">PMC6397535</ArticleId><ArticleId IdType="pubmed">30760592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben&#xed;tez-Temi&#xf1;o B., Davis-L&#xf3;pez de Carrizosa M.A., Morcuende S., Matarredona E.R., de la Cruz R.R., Pastor A.M. Functional diversity of neurotrophin actions on the oculomotor system. Int. J. Mol. Sci. 2016;17:2016. doi: 10.3390/ijms17122016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17122016</ArticleId><ArticleId IdType="pmc">PMC5187816</ArticleId><ArticleId IdType="pubmed">27916956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernfors P., Henschen A., Olson L., Persson H. Expression of Nerve Growth Factor Receptor mRNA Is Developmentally Regulated and Increased after Axotomy in Rat Spinal Cord Motoneurons. Neuron. 1989;2:1605&#x2013;1613. doi: 10.1016/0896-6273(89)90049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(89)90049-4</ArticleId><ArticleId IdType="pubmed">2560649</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Hucha S., Carrero-Rojas G., de Sevilla M.E.F., Ben&#xed;tez-Temi&#xf1;o B., de Carrizosa M.A.D.L., Pastor A.M., Morcuende S. Sources and lesion-induced changes of VEGF expression in brainstem motoneurons. Brain Struct. Funct. 2020;225:1033&#x2013;1053. doi: 10.1007/s00429-020-02057-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-020-02057-y</ArticleId><ArticleId IdType="pubmed">32189115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K., Ostwal P., Sumitha R., Shruthi S., Varghese A.M., Mishra P., Manohari S.G., Sagar B.C., Sathyaprabha T.N., Nalini A., et al. Role of VEGF and VEGFR2 receptor in reversal of ALS-CSF induced degeneration of NSC-34 motor neuron cell line. Mol. Neurobiol. 2015;51:995&#x2013;1007. doi: 10.1007/s12035-014-8757-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8757-y</ArticleId><ArticleId IdType="pubmed">24880751</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkowska A., Gutowska I., Goschorska M., Nowacki P., Chlubek D., Baranowska-Bosiacka I. Energy metabolism of the brain, including the cooperation between astrocytes and neurons, especially in the context of glycogen metabolism. Int. J. Mol. Sci. 2015;16:25959&#x2013;25981. doi: 10.3390/ijms161125939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms161125939</ArticleId><ArticleId IdType="pmc">PMC4661798</ArticleId><ArticleId IdType="pubmed">26528968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung W.S., Clarke L.E., Wang G.X., Stafford B.K., Sher A., Chakraborty C., Joung J., Foo L.C., Thompson A., Chen C., et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504:394&#x2013;400. doi: 10.1038/nature12776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12776</ArticleId><ArticleId IdType="pmc">PMC3969024</ArticleId><ArticleId IdType="pubmed">24270812</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Est&#xe9;vez A.G., Beckman J.S. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Rev. 2004;47:263&#x2013;274. doi: 10.1016/j.brainresrev.2004.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2004.05.003</ArticleId><ArticleId IdType="pubmed">15572176</ArticleId></ArticleIdList></Reference><Reference><Citation>Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 2011;11:775&#x2013;787. doi: 10.1038/nri3086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3086</ArticleId><ArticleId IdType="pubmed">22025055</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691&#x2013;705. doi: 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry V.H., Nicoll J.A.R., Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 2010;6:193&#x2013;201. doi: 10.1038/nrneurol.2010.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.17</ArticleId><ArticleId IdType="pubmed">20234358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberg G.W. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312&#x2013;318. doi: 10.1016/0166-2236(96)10049-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(96)10049-7</ArticleId><ArticleId IdType="pubmed">8843599</ArticleId></ArticleIdList></Reference><Reference><Citation>Krum J.M., Rosenstein J.M. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp. Neurol. 1998;154:57&#x2013;65. doi: 10.1006/exnr.1998.6930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1998.6930</ArticleId><ArticleId IdType="pubmed">9875268</ArticleId></ArticleIdList></Reference><Reference><Citation>Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp. Neurol. 2008;212:108&#x2013;117. doi: 10.1016/j.expneurol.2008.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2008.03.019</ArticleId><ArticleId IdType="pmc">PMC2478519</ArticleId><ArticleId IdType="pubmed">18482723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennmyr F., Ata K.A., Funa K., Olsoon Y., Ter&#xe9;nt A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J. Neuropathol. Exp. Neurol. 1998;57:874&#x2013;882. doi: 10.1097/00005072-199809000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199809000-00009</ArticleId><ArticleId IdType="pubmed">9737551</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta L., Morcuende S., Silva-Hucha S., Pastor A.M., de la Cruz R.R. Vascular endothelial growth factor (VEGF) prevents the downregulation of the cholinergic phenotype in axotomized motoneurons of the adult rat. Front. Mol. Neurosci. 2018;11:241. doi: 10.3389/fnmol.2018.00241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00241</ArticleId><ArticleId IdType="pmc">PMC6052088</ArticleId><ArticleId IdType="pubmed">30050409</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttner U., B&#xfc;ttner-Ennever J.A. Present concepts of oculomotor organization. Prog. Brain Res. 2006;151:1&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16221584</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann L., Morado-D&#xed;az C.J., Carrizosa M.A.D.L., de la Cruz R.R., May P.J., Streicher J., Pastor A.M., Blumer R. Axons giving rise to the palisade endings of feline extraocular muscles display motor features. J. Neurosci. 2013;33:2784&#x2013;2793. doi: 10.1523/JNEUROSCI.4116-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4116-12.2013</ArticleId><ArticleId IdType="pmc">PMC4811327</ArticleId><ArticleId IdType="pubmed">23407938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacoby J., Ko K., Weiss C., Rushbrook J.I. Systematic variation in myosin expression along extraocular muscle fibres of the adult rat. J. Muscle Res. Cell Motil. 1990;11:25&#x2013;40. doi: 10.1007/BF01833323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01833323</ArticleId><ArticleId IdType="pubmed">2141031</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G., Tapia J.C., Lichtman J.W., Fox M.A., Sanes J.R. Shared resistance to aging and als in neuromuscular junctions of specific muscles. PLoS ONE. 2012;7:e34640. doi: 10.1371/journal.pone.0034640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034640</ArticleId><ArticleId IdType="pmc">PMC3317643</ArticleId><ArticleId IdType="pubmed">22485182</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjust A.E., Danielsson A., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Domell&#xf6;f F.P. Impact of amyotrophic lateral sclerosis on slow tonic myofiber composition in human extraocular muscles. Investig. Ophthalmol. Vis. Sci. 2017;58:3708&#x2013;3715. doi: 10.1167/iovs.17-22098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.17-22098</ArticleId><ArticleId IdType="pubmed">28738414</ArticleId></ArticleIdList></Reference><Reference><Citation>Heerssen H.M., Segal R.A. Location, location, location: A spatial view of neurotrophin signal transduction. Trends Neurosci. 2002;25:160&#x2013;165. doi: 10.1016/S0166-2236(02)02144-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(02)02144-6</ArticleId><ArticleId IdType="pubmed">11852149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez R.G., Silva-Hucha S., Morcuende S., de la Cruz R.R., Pastor A.M., Ben&#xed;tez-Temi&#xf1;o B. Extraocular motor system exhibits a higher expression of neurotrophins when compared with other brainstem motor systems. Front. Neurosci. 2017;11:399. doi: 10.3389/fnins.2017.00399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00399</ArticleId><ArticleId IdType="pmc">PMC5504184</ArticleId><ArticleId IdType="pubmed">28744196</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo P.M., de la Cruz R.R., Pastor A.M. Synaptic loss and firing alterations in Axotomized Motoneurons are restored by vascular endothelial growth factor (VEGF) and VEGF-B. Exp. Neurol. 2018;304:67&#x2013;81. doi: 10.1016/j.expneurol.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.03.004</ArticleId><ArticleId IdType="pubmed">29522757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Zhou S., Cai H., Gong Z., Zang D. VEGF levels in CSF and serum in mild ALS patients. J. Neurol. Sci. 2014;346:216&#x2013;220. doi: 10.1016/j.jns.2014.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.08.031</ArticleId><ArticleId IdType="pubmed">25204587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti J.N., Shah S.K., McCloskey D.P., Goodman J.H., Elkady A., Atassi H., Hylton D., Rudge J.S., Scharfman H.E., Croll S.D. Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience. 2008;151:232&#x2013;241. doi: 10.1016/j.neuroscience.2007.09.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.09.083</ArticleId><ArticleId IdType="pmc">PMC2212620</ArticleId><ArticleId IdType="pubmed">18065154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Investig. 2003;111:1843&#x2013;1851. doi: 10.1172/JCI200317977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200317977</ArticleId><ArticleId IdType="pmc">PMC161428</ArticleId><ArticleId IdType="pubmed">12813020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Nennesmo I., Fadeel B., Henter J.I. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 2004;56:564&#x2013;567. doi: 10.1002/ana.20223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20223</ArticleId><ArticleId IdType="pubmed">15389897</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakora D., Mulcrone P., Meyer M., Lewis C., Bernau K., Gowing G., Zimprich C., Aebischer P., Svendsen C.N., Suzuki M. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol. Ther. 2013;21:1602&#x2013;1610. doi: 10.1038/mt.2013.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.108</ArticleId><ArticleId IdType="pmc">PMC3734670</ArticleId><ArticleId IdType="pubmed">23712039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi N.R., Bedard A.M., Hincke M.T., Tetzlaff W. Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy. Eur. J. Neurosci. 1996;8:1018&#x2013;1029. doi: 10.1111/j.1460-9568.1996.tb01588.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1996.tb01588.x</ArticleId><ArticleId IdType="pubmed">8743749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata Y., Okuya M., Watanabe R., Honda M. Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease. Brain Res. 1982;244:223&#x2013;229. doi: 10.1016/0006-8993(82)90081-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(82)90081-6</ArticleId><ArticleId IdType="pubmed">6288185</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgo L., de Belleroche J., Rossi M., Steiner T.J. Characterisation of the distribution of choline acetyltransferase messenger RNA in human spinal cord and its depletion in motor neurone disease. J. Neurol. Sci. 1992;112:126&#x2013;132. doi: 10.1016/0022-510X(92)90141-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(92)90141-7</ArticleId><ArticleId IdType="pubmed">1469422</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y., Imai S., Nakanishi I., Ichikawa T., Deguchi T. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol. Int. 1995;45:933&#x2013;939. doi: 10.1111/j.1440-1827.1995.tb03418.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.1995.tb03418.x</ArticleId><ArticleId IdType="pubmed">8808298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T. Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis. J. Neurochem. 1989;52:636&#x2013;640. doi: 10.1111/j.1471-4159.1989.tb09167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1989.tb09167.x</ArticleId><ArticleId IdType="pubmed">2911033</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y. Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathol. Int. 1999;49:921&#x2013;937. doi: 10.1046/j.1440-1827.1999.00977.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1827.1999.00977.x</ArticleId><ArticleId IdType="pubmed">10594838</ArticleId></ArticleIdList></Reference><Reference><Citation>Morcuende S., Ben&#xed;tez-Temi&#xf1;o B., Pecero M.L., Pastor A.M., de la Cruz R.R. Abducens internuclear neurons depend on their target motoneurons for survival during early postnatal development. Exp. Neurol. 2005;195:244&#x2013;256. doi: 10.1016/j.expneurol.2005.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.05.003</ArticleId><ArticleId IdType="pubmed">15935346</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis-L&#xf3;pez de Carrizosa M.A., Morado-D&#xed;az C.J., Tena J.J., Ben&#xed;tez-Temi&#xf1;o B., Pecero M.L., Morcuende S., de la Cruz R.R., Pastor A.M. Complementary actions of BDNF and neurotrophin-3 on the firing patterns and synaptic composition of motoneurons. J. Neurosci. 2009;29:575&#x2013;587. doi: 10.1523/JNEUROSCI.5312-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5312-08.2009</ArticleId><ArticleId IdType="pmc">PMC6664940</ArticleId><ArticleId IdType="pubmed">19144857</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Cruz R.R., Delgado-Garc&#xed;a J.M., Pastor A.M. Discharge characteristics of axotomized abducens internuclear neurons in the adult cat. J. Comp. Neurol. 2000;427:391&#x2013;404. doi: 10.1002/1096-9861(20001120)427:3&lt;391::AID-CNE6&gt;3.0.CO;2-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9861(20001120)427:3&lt;391::AID-CNE6&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">11054701</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastor A.M., Delgado-Garc&#xed;a J.M., Mart&#xed;nez-Guijarro F.J., L&#xf3;pez-Garc&#xed;a C., de la Cruz R.R. Response of abducens internuclear neurons to axotomy in the adult cat. J. Comp. Neurol. 2000;427:370&#x2013;390. doi: 10.1002/1096-9861(20001120)427:3&lt;370::AID-CNE5&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9861(20001120)427:3&lt;370::AID-CNE5&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">11054700</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Cruz R.R., Ben&#xed;tez-Temi&#xf1;o B., Pastor A.M. Intrinsic determinants of synaptic phenotype: An experimental study of abducens internuclear neurons connecting with anomalous targets. Neuroscience. 2002;112:759&#x2013;771. doi: 10.1016/S0306-4522(02)00133-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(02)00133-1</ArticleId><ArticleId IdType="pubmed">12088736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lams B.E.E., Isacson O., Sofroniew M.V. Loss of transmitter-associated enzyme staining following axotomy does not indicate death of brainstem cholinergic neurons. Brain Res. 1988;475:401&#x2013;406. doi: 10.1016/0006-8993(88)90635-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(88)90635-X</ArticleId><ArticleId IdType="pubmed">3214743</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura J., Ajiki K., Ichikawa T., Misawa H. Changes of expression levels of choline acetyltransferase and vesicular acetylcholine transporter mRNAs after transection of the hypoglossal nerve in adult rats. Neurosci. Lett. 1997;236:95&#x2013;98. doi: 10.1016/S0304-3940(97)00763-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(97)00763-5</ArticleId><ArticleId IdType="pubmed">9404820</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Salvaterra P.M., Loera S., Chiu A.Y. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J. Neurosci. Res. 1997;47:134&#x2013;143. doi: 10.1002/(SICI)1097-4547(19970115)47:2&lt;134::AID-JNR2&gt;3.0.CO;2-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19970115)47:2&lt;134::AID-JNR2&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">9008144</ArticleId></ArticleIdList></Reference><Reference><Citation>Morado-D&#xed;az C.J., Matarredona E.R., Morcuende S., Talaver&#xf3;n R., Davis-L&#xf3;pez de Carrizosa M.A., de la Cruz R.R., Pastor A.M. Neural progenitor cell implants in the lesioned medial longitudinal fascicle of adult cats regulate synaptic composition and firing properties of abducens internuclear neurons. J. Neurosci. 2014;34:7007&#x2013;7017. doi: 10.1523/JNEUROSCI.4231-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4231-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608105</ArticleId><ArticleId IdType="pubmed">24828653</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D., Carmeliet P. VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochim. Biophys. Acta. 2006;1762:1109&#x2013;1121. doi: 10.1016/j.bbadis.2006.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.04.005</ArticleId><ArticleId IdType="pubmed">16784838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo L.B., Ram&#xed;rez-Jarqu&#xed;n U.N., Lazo-G&#xf3;mez R., Tapia R. Trophic factors as modulators of motor neuron physiology and survival: Implications for ALS therapy. Front. Cell. Neurosci. 2014;8:61. doi: 10.3389/fncel.2014.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00061</ArticleId><ArticleId IdType="pmc">PMC3937589</ArticleId><ArticleId IdType="pubmed">24616665</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Treleaven C.M., Fidler J.A., Hester M., Haidet A., Handy C., Rao M., Eagle A., Matthews J.C., Taksir T.V., et al. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice. Mol. Ther. 2010;18:2075&#x2013;2084. doi: 10.1038/mt.2010.206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2010.206</ArticleId><ArticleId IdType="pmc">PMC2997594</ArticleId><ArticleId IdType="pubmed">20859261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>